Bile composition in patients with ileal resection due to Crohn's Disease

Inflammatory Bowel Diseases

Volumn 4, Issue 2, 1998, Pages 89-94

  Lapidus, Annika ^a   Einarsson, Curt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bile acid; Biliary lipid composition; Bilirubin; Cholesterol saturation; Crohn's disease; Gallstone; Ileal resection

Indexed keywords

BILIRUBIN; CHOLESTEROL;

ADULT; ARTICLE; BILE; CHEMISTRY; CHOLELITHIASIS; CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; ILEITIS; MALE; METABOLISM; MIDDLE AGED; PROBABILITY; REFERENCE VALUE; RISK FACTOR;

ADULT; BILE; BILIRUBIN; CHOLELITHIASIS; CHOLESTEROL; CROHN DISEASE; FEMALE; HUMANS; ILEITIS; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RISK FACTORS;

EID: 0032064172     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780040204     Document Type: Article

References (55)

1. Cohen S, Kaplan M, Gottlieb L, Patterson J. Liver disease and gallstones in regional enteritis. Gastroenterotogy 1971;60:237-45.
2. Heaton KW, Read AE. Gallstones in patients with disorders of the terminal ileum and disturbed bile salt metabolism. BMJ 1969;3: 494-6.
3. Hill GL, Mair WSJ, Goligher JC. Gallstones after ileostomy and ileal resection. Gut 1975;16:932-6.
4. Whorwell PJ, Hawkins R, Dewbury K, Wright R. Ultrasound survey of gallstones and other hepatobiliary disorders in patients with Crohn's disease. Dig Dis Sci 1984;29:930-3.
5. Hutchinson R, Tyrrell PNM, Kumar D, Dunn JA, Li JKW, Allan RN. Pathogenesis of gall stones in Crohn's disease: an alternative explanation. Gut 1994;35:94-7.
6. Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968;47:1043-52.
7. Lamont JT, Carey MC. Cholesterol gallstone formation 2. Pathobiology and pathomechanics. Prog Liver Dis 1992;10:165-91.
8. Hofmann AF. Bile acids. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The liver: Biology and pathobiology, 3rd ed. New York: Raven Press, 1994:677-718.
9. Carey MC, Duane WC. Enterohepatic circulation. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The liver: Biology and pathobiology, 3rd ed. New York: Raven Press, 1994:719-67.
10. Heaton KW. Disturbances of bile acid metabolism in intestinal disease. Clin Gastroenterol 1976;6:69-89.
11. Grundy SM, Ahrens EH Jr, Salen G. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 1971;78:94-121.
12. Dowling RH, Bell GD, White J. Lithogenic bile in patients with ileal dysfunction. Gut 1972;13:415-20.
13. Lapidus A, Einarsson K. Effects of ileal resection on biliary lipids and bile acid composition in patients with Crohn's disease. Gut 1991;32:1488-91.
14. Bickerstaff KJ, Moosa AR. Effects of resection or bypass of the distal ileum on the lithogenicity of bile. Am J Surg 1983;145:34-40.
15. Pitt HA, Lewinski MA, Muller EL, Porter-Fink V, DenBesten L. Ileal resection-induced gallstones: Altered bilirubin or cholesterol metabolism? Surgery 1984;96:154-62.
16. Berk PD, Noyer C. Bilirubin metabolism and the hereditary hyperbilirubinemias. Sem Liver Dis 1994;14:325-51.
17. Jendrassik L, Grof P. Vereinfachte photometrische metoden zur bestimmung des blutbilirubins. Biochem Z 1938;297:81-9.
18. Berglund L, Angelin B, Blomstrand R, Drummond G, Kappas A. Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic oxygenase activity in normal human subjects. Hepotology 1988;8:625-31.
19. Roda A, Festi D, Sama C, et al. Enzymatic determination of cholesterol in bile. Clin Chim Acta 1975;64:337-41.
20. Rouser G, Fleischer S, Yamamoto A. Two dimensional thin-layer chromatographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots. Lipids 1970;5: 494-6.
21. Fausa O, Skålhegg BA. Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3α-hydroxysteroid dehydrogenase. Scand J Gastroenterol 1974;9:249-54.
22. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-55.
23. Angelin B, Einarsson K, Leijd B. Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest 1979;9:185-90.
24. Marks JW, Conley DR, Capretta TL, et al. Gallstone prevalence and biliary lipid composition in inflammatory bowel disease. Dig Dis Sci 1977;22:1097-100.
25. Rutgeerts P, Ghoos Y, Vantrappen G, Fevery I. Biliary lipid composition in patients with nonoperated Crohn's disease. Dig Dis Sci 1986;31:27-32.
26. Rutgeerts P, Ghoos Y, Vantrappen G. Effect of partial ileocolectomy and Crohn's disease on biliary lipid secretion. Dig Dis Sci 1987;32:1231-8.
27. Färkkilä MA. Biliary cholesterol and lithogenicity of bile in patients after ileal resection. Surgery 1988;104:18-25.
28. Thaysen H, Bruusgaard A, Eriksen B. Evaluation of the efficiency of bile salt recirculation in patients with terminal ileopathies by means of deoxycholate determination in duodenal aspirates. Scand J Gastroenterol 1970;5:39-47.
29. Mallory A, Kern FJ, Smith J, Savage D. Patterns of bile acids and microflora in the human small intestine. I. Bile acids. Gastroenterology 1973;64:26-33.
30. Kruis W, Kalek HD, Stellaard F, Paumgartner G. Altered faecal bile acid pattern in patients with inflammatory bowel disease. Digestion 1986;35:189-98.
31. Abaurre R, Gordon SG, Mann JG, Kern FJ. Fasting bile salt pool size and composition after ileal resection. Gastroenterology 1969; 57:679-88.
32. Rutgeerts P, Ghoos Y, Vantrappen G. Kinetics of primary bile acids in patients with non-operated Crohn's disease. Eur J Clin Invest 1982;12:135-13.
33. Fiasse R, Eyssen HJ, Leonard PJ, Dive CH. Faecal bile acid analysis and intestinal absorption in Crohn's disease before and after ileal resection. Eur J Clin Invest 1983;13:185-92.
34. Fromm H, Carlson GL, Hofmann AF, Farivar S, Amin P. Metabolism in man of 7-ketolithocholic acid: a precursor of chenodeoxycholic and ursodeoxycholic acid. Am J Physiol 1980;239:161-6.
35. Fromm H, Sarva RP, Bazzoli F. Formation of ursodeoxycholic acid from chenodeoxycholic acid in the human colon: studies of the role of 7-ketolithocholic acid as an intermediate. J Lipid Res 1983;24:841-53.
36. Miwa U, Yamamota M, Nishida T, Yao T. Transformation of chenodeoxycholic acid to ursodeoxycholic acid in patients with Crohn's disease. Gastroenterology 1986;90:718-23.
37. Hellström K, Sjövall J. On the origin of lithocholic and ursodeoxycholic acids in man. Acta Physiol Scand 1961;51:218-23.
38. Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol lithiasis. Dig Dis Sci 1982;27:833-56.
39. Vantrappen G, Ghoos Y, Rutgeerts P, Janssens J. Bile acid studies in uncomplicated Crohn's disease. Gut 1977;18:730-5.
40. 2 acid. Gut 1982;23:751-7.
41. Tint GS, Salen G, Shefer S. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterohgy 1986;91:1007-18.
42. Nilsell K, Angelin B, Leijd B, Einarsson K. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion. Gastroenterology 1983;85:1248-56.
43. Hardison WGM, Grundy SM. Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology 1984;87:130-5.
44. Leiss O, von Bergmann K, Streicher U, Strotkoetler H. Effect of three different dihydroxy bile acids on intestinal cholesterol absorption in normal volunteers. Gastroenterology 1984;87:144-9.
45. Tazuma S, Sasaki H, Mizuno S, et al. Effect of ursodeoxycholic acid administration on nucleation time in human gallbladder bile. Gastroenlerology 1989;97:173-8.
46. Jüngst D, Brenner G, Pratschke E, Paumgartner G. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. J Hepatol 1989;8:1-6.
47. Sahlin S, Ahlberg J, Angelin B, Reihner E, Einarsson K. Nucleation time of gallbladder bile in gallstone patients: influence of bile acid treatment. Gut 1991;32:1554-7.
48. Lester R, Schmid R. Intestinal absorption of bile pigments. I. The enterohepatic circulation of bilirubin in the rat. J Clin Invest 1963; 42:736-46.
49. Lester R, Schmid R. Intestinal absorption of bile pigments. II. Bilirubin absorption in man. N Engl J Med 1963;269:178-82.
50. Poland RL, Odell GB. Physiologic jaundice: the enterohepatic circulation of bilirubin. N Engl J Med 1971;284:1-6.
51. Gollan J, Hammaker L, Licko V, Schmid R. Bilirubin kinetics in intact rats and isolated perfused liver: evidence for hepatic deconjugation of bilirubin glucuronides. J Clin Invest 1981;67:1003-15.
52. Billing BH. Intestinal and renal metabolism of bilirubin including enterohepatic circulation. In: Ostrow JD, Eds. Bile pigments and jaundice. Molecular, metabolic and medical aspects. New York: Marcel Dekker, 1986: 255-69.
53. Brink MA, Méndez-Sánchez N, Carey MC. Bilirubin cycles enterohepatically after ileal resection in the rat. Gastroenterology 1996;110:1945-57.
54. Dawes L, Stryker S, Rege R, Nahrwold D. Gallbladder bile composition in Crohn's disease. Surg Forum 1991;42:188-9.
55. Brink MA, Slors JFM, Carey MC, Keulemans YCA, Groen AK, Tytgat GNJ. Enterohepatic cycling of bilirubin in patients with ileal Crohn's disease: a pathophysiological mechanism for pigment gallstone disease. Gastroenterology 1996;110:A1159.